← Eichor
Study identifier: NCT06602167 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Condition: Capecitabine · Hand-foot Syndrome · Electroacupuncture  ·  Sponsor: Affiliated Hospital of Qinghai University

PhaseNA
Planned participants220
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersYes

About this study

This study hypothesizes that electroacupuncture combined with self-administered acupressure plus doctor-prescribed treatment is effective in preventing Hand-Foot Syndrome (HFS) caused by capecitabine. It aims to explore the effectiveness of this combined approach in preventing HFS in patients with malignant tumors undergoing oral capecitabine treatment. Further exploration of prevention and treatment methods may enhance the quality of life for patients during the treatment process.

This description comes directly from the study's public registry record.

Talk to the study team

Jiuda Zhao  ·  869716230893  ·  jiudazhao@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Qinghai University Affiliated HospitalXining, Qinghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06602167